SCHEMBL551222

SCHEMBL551222

C=C(Br)/C=C/c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.54
HDAC3 O15379 2/20 0.54
HDAC4 P56524 2/20 0.54
HDAC1 Q13547 2/20 0.54
HDAC2 Q92769 2/20 0.54
HDAC8 Q9BY41 2/20 0.54
HDAC6 Q9UBN7 2/20 0.54
PLIN1 O60240 2/20 0.54
LMNA P02545 2/20 0.54
RECQL P46063 2/20 0.54
PLIN5 Q00G26 2/20 0.54
ABHD5 Q8WTS1 2/20 0.54
ALDH1A1 P00352 2/20 0.54
F3 P13726 2/20 0.54
TNKS O95271 1/20 0.54
HCAR2 Q8TDS4 1/20 0.54
HDAC7 Q8WUI4 1/20 0.54
HDAC10 Q969S8 1/20 0.54
HDAC11 Q96DB2 1/20 0.54
TNKS2 Q9H2K2 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL551223 1.00 MAPT (0.54) MAPTHDAC3HDAC4HDAC1HDAC2
SCHEMBL869685 0.80 MAPT (0.58) MAPTHDAC3HDAC4HDAC1HDAC2
SCHEMBL12261578 0.80 MAPT (0.58) MAPTHDAC3HDAC4HDAC1HDAC2
SCHEMBL1999708 0.80 MAPT (0.58) MAPTHDAC3HDAC4HDAC1HDAC2
SCHEMBL1999706 0.80 MAPT (0.58) MAPTHDAC3HDAC4HDAC1HDAC2
SCHEMBL21418158 0.79 MAPT (0.48) MAPTLMNARECQLALDH1A1CYP1A2
SCHEMBL12252392 0.78 MAPT (0.56) MAPTHDAC3HDAC4HDAC1HDAC2
SCHEMBL4856786 0.78 MAPT (0.56) MAPTHDAC3HDAC4HDAC1HDAC2
SCHEMBL27640189 0.78 MAPT (0.56) MAPTHDAC3HDAC4HDAC1HDAC2
SCHEMBL30688107 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8110695-B2 Compounds and compositions containing silicon and/or other heteroatoms and/or metals and methods of making and using them WELKER MARK E (US) 2012-02-07 US disclosed
US-8110695-B2 Compounds and compositions containing silicon and/or other heteroatoms and/or metals and methods of making and using them WELKER MARK E (US) 2012-02-07 US disclosed
US-8110695-B2 Compounds and compositions containing silicon and/or other heteroatoms and/or metals and methods of making and using them WELKER MARK E (US) 2012-02-07 US disclosed
US-20100056801-A1 Compounds And Compositions Containing Silicon And/Or Other Heteroatoms And/Or Metals And Methods of Making And Using Them WELKER MARK E 2010-03-04 US disclosed
US-20100056801-A1 Compounds And Compositions Containing Silicon And/Or Other Heteroatoms And/Or Metals And Methods of Making And Using Them WELKER MARK E 2010-03-04 US disclosed
US-20100056801-A1 Compounds And Compositions Containing Silicon And/Or Other Heteroatoms And/Or Metals And Methods of Making And Using Them WELKER MARK E 2010-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056801-A1 Compounds And Compositions Containing Silicon And/Or Other Heteroatoms And/Or Metals And Methods of Making And Using Them CA6, SOD1, CA1 MAPT 2126/4885HDAC3 646/4885HDAC4 1119/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.